Increased phosphorylation of the cardiac ryanodine receptor (RyR)2 by protein kinase A (PKA) at the phosphoepitope encompassing Ser2808 has been advanced as a central mechanism in the pathogenesis of cardiac arrhythmias and heart failure. In this scheme, persistent activation of the sympathetic system during chronic stress leads to PKA "hyperphosphorylation" of RyR2-S2808, which increases Ca 2ϩ release by augmenting the sensitivity of the RyR2 channel to diastolic Ca 2ϩ . This gain-of-function is postulated to occur with the unique participation of RyR2-S2808, and other potential PKA phosphorylation sites have been discarded. Although it is clear that RyR2 is among the first proteins in the heart to be phosphorylated by ␤-adrenergic stimulation, the functional impact of phosphorylation in excitation-contraction coupling and cardiac performance remains unclear. We used gene targeting to produce a mouse model with complete ablation of the RyR2-S2808 phosphorylation site (RyR2-S2808A). Whole-heart and isolated cardiomyocyte experiments were performed to test the role of ␤-adrenergic stimulation and PKA phosphorylation of Ser2808 in heart failure progression and cellular Ca 2ϩ handling. We found that the RyR2-S2808A mutation does not alter the ␤-adrenergic response, leaves cellular function almost unchanged, and offers no significant protection in the maladaptive cardiac remodeling induced by chronic stress. Moreover, the RyR2-S2808A mutation appears to modify single-channel activity, although modestly and only at activating [Ca 2ϩ ]. Taken together, these results reveal some of the most important effects of PKA phosphorylation of RyR2 but do not support a major role for RyR2-S2808 phosphorylation in the pathogenesis of cardiac dysfunction and failure. (Circ Res. 2007;101:819-829.) 
I n cardiac muscle, Ca 2ϩ release channels/ryanodine receptors (RyR2) of sarcoplasmic reticulum (SR) are key players in excitation-contraction coupling, a finely orchestrated series of events that link electrical stimuli with mechanical contractions. Depolarization of the external membrane opens L-type Ca 2ϩ channels, allowing a small inward Ca 2ϩ current (I Ca ) that triggers massive Ca 2ϩ release from the SR. This Ca 2ϩ amplification process, Ca 2ϩ -induced Ca 2ϩ release, is mediated by RyR2s and provides the majority of Ca 2ϩ that myofilaments need for contraction. Relaxation occurs when Ca 2ϩ detaches from the myofilaments and is cycled back into the SR by the work of the Ca 2ϩ -ATPase, a process that is regulated by phospholamban (PLB). 1 Increased metabolic demand during periods of stress or exercise triggers release of catecholamines, which stimulate ␤-adrenergic receptors in the heart. Activation of the ␤-adrenergic receptor pathway triggers a cascade of events that increase cAMP, which in turn activates protein kinase (PK)A. PKA then phosphorylates several target proteins in the sarcolemma, the SR, and myofilaments, notably, L-type Ca 2ϩ channels, PLB, RyR2, and troponin I and C, leading to an increased Ca 2ϩ entry, enhanced Ca 2ϩ -induced Ca 2ϩ release, and faster Ca 2ϩ uptake and relaxation rates, all of which contribute to the inotropic and lusitropic effects of ␤-adrenergic stimulation on the heartbeat. [1] [2] [3] Despite the fact that RyR2 are among the first proteins to undergo phosphorylation by ␤-adrenergic receptor stimulation of cardiac muscle, 4, 5 the functional impact of this reaction remains unclear. On the one hand, Li et al 6 have found that PKA phosphorylation of RyR2 has little functional relevance for diastolic Ca 2ϩ release if SR Ca 2ϩ levels remain constant. On the other hand, Marks et al have postulated that PKA phosphorylation of RyR2 is so consequential for intracellular Ca 2ϩ homeostasis that derangement of this process may be the basis for some forms of cardiac arrhythmias 7 and heart failure (HF). 8 -10 In between these 2 extremes, other results, mainly from in vitro experiments, imply that PKA phosphorylation increases, 4, 11 decreases, [12] [13] or has no effect 14 on RyR2 activity.
The variable and apparently contradicting results of PKA phosphorylation may be attributable to the presence of multiple phosphorylation sites on the RyR2 protein 4, 15, 16 that may influence channel activity differently. However, Wehrens et al 10 have reported that PKA phosphorylates mouse RyR2 at a single and unique residue, Ser2808 (corresponding to Ser2809 in human RyR2) and that genetic ablation of this phosphorylation site prevents PKA activation of RyR2 and protects hearts from the maladaptive cardiac remodeling that follows myocardial infarction. In overt HF, Marks and colleagues have detected "hyperphosphorylation" of Ser2809 in canine and human hearts, 8 -10 postulating that this reaction is the basis for the increased Ca 2ϩ leak and decreased SR Ca 2ϩ content that are characteristic of HF, but these findings were not confirmed by others. 6, 14, 16, 17 Thus, the role of PKA phosphorylation, and especially of Ser2808 phosphorylation, remains unclear.
We generated mice with genetic ablation of the Ser2808 phosphoepitope (RyR2-S2808A) and used whole-heart, isolated cardiomyocyte and single-channel experiments to test the role of ␤-adrenergic stimulation and PKA phosphorylation of Ser2808 in HF progression, cellular Ca 2ϩ handling, and RyR2 activity. We found that the RyR2-S2808A mutation modifies single-channel activity, albeit modestly and at activating [Ca 2ϩ ] only, allows for normal ␤-adrenergic stimulation of [Ca 2ϩ ] i transients, leaves cellular function almost unaltered, and offers no significant protection in the maladaptive cardiac remodeling induced by chronic stress.
Materials and Methods

Experimental Animals
RyR2-S2808A mice and age-matched wild-type (WT) littermates were maintained and studied according to the protocol approved by the Institutional Animal Care and Use Committees of the University of Wisconsin Madison and by the Association for Assessment and Accreditation of Laboratory Care International.
Generation of the RyR2-S2808A Mice
Mice with the RyR2-S2808A mutation were generated by homologous recombination.
An expanded Materials and Methods section is available in the online data supplement at http://circres.ahajournals.org.
Results
Generation of RyR2-S2808A Mice and Characterization With Phospho-Specific Antibody
We used homologous recombination to generate mice with total ablation of the RyR2-S2808 phosphoepitope by replacing Ser2808 with the nonphosphorylatable residue Ala (Figure 1A) . The resultant RyR2-S2808A mice developed normally, displayed no overt phenotypic differences compared with their WT littermates, and propagated at the expected Mendelian frequencies (61 WT [ Figure 1C ), and immunocytochemistry ( Figure  1D ) experiments confirmed that the RyR2-S2808A substitution was present in hearts of the mutant mice. Western blots using the phospho-specific antibody RyR2-pS2808 (ref. 15 ) displayed a strong band in WT but no signal in RyR2-S2808A SR-enriched microsomes ( Figure 1E ).
Echocardiographic Analysis of WT and RyR2-S2808A Mice
Hearts of RyR2-S2808A mice were structurally normal in histologic ( Figure 2A ) and echocardiographic ( Figure 2B ) analyses. However, following 4 weeks of aortic constriction, both RyR2-S2808A mice and their WT littermates exhibited evident cardiac remodeling and progressive systolic dysfunction. Cardiac hypertrophy was apparent in explanted banded hearts (Figure 2A ), and the ratio of left ventricular mass/body weight increased to a greater extent in WT (82Ϯ10%) than in RyR2-S2808A (61Ϯ13%) mice (nϭ6 to 7), but the difference did not reach statistical significance (Pϭ0.25). A similar trend toward cardioprotection was noted in the progression of RyR2-S2808A mice toward systolic dysfunction, both in the functional index (0.77Ϯ0.1 in WT versus 0.85Ϯ0.05 in RyR2-S2808A) and the stroke volume (25.8Ϯ9 L in WT versus 34.1Ϯ9.7 L in RyR2-S2808A). However, like the structural parameters, functional differences were modest and lacked statistical significance (see other echocardiographic parameters in Table I in the online data supplement). Thus, ablation of the RyR2-S2808 phosphorylation site does not appear to impact significantly the maladaptive cardiac remodeling that follows chronic stress.
S2808 Is Not the Only PKA Site in RyR2
Wehrens et al 10 reported that RyR2 immunoprecipitated from RyR2-S2808A mice could not be phosphorylated by PKA and postulated that S2808 is the only PKA site in the entire RyR2 protein. Here we show that immunoprecipitated RyR2-S2808A protein ( Figure 3A ) was phosphorylated by the catalytic subunit of PKA. WT and RyR2-S2808A proteins were either untreated or pretreated with alkaline phosphatase (AkPh) before incubation with PKA and [␥-32 P]ATP to assess the level of basal phosphorylation; values were then normalized to that of maximally dephosphorylated (AkPh-treated) WT-RyR2 (100%). Samples incubated with the phosphorylation cocktail minus PKA showed no incorporation of radioactivity ( Figure 3A ; ϪPKA, 0%), indicating that no endogenous kinases participated in this reaction and that all phosphorylation was PKA specific. Untreated WT-RyR2 incorporated 71Ϯ7% of the total [␥-32 P]ATP, indicating that only Ϸ30% of PKA phosphorylation sites were basally phosphorylated. Probing with phospho-specific antibodies ( Figure 3C ) reveals that S2808 is mostly responsible for this basal phosphorylation; S2030, another PKA-specific site, 16 appears completely dephosphorylated under basal conditions. In comparison, untreated RyR2-S2808A could be phosphorylated to 44Ϯ5% of WT-RyR2 ( Figure 3A ) and this value changed only slightly by pretreatment with AkPh (36Ϯ3%), suggesting that more than half of the total PKA phosphorylation sites are available for phosphorylation and that they are mostly dephosphorylated under basal conditions. Indeed, Figure 3C shows that S2030 is a phosphoepitope still available for phosphorylation in RyR2-S2808A and is likely responsible for the incorporation of [␥-32 P]ATP detected in the autoradiogram. These complementary approaches strongly suggest that PKA phosphorylates at least 2 sites in WT-RyR2, S2808 and S2030, which are highly and barely phosphorylated, respectively, under basal conditions in mouse hearts ( Figure 3B ). 16, 17, 18 
In Vivo Phosphorylation of RyR2
Next, we assessed the in vivo phosphorylation state of the 3 known phosphoepitopes of RyR2 and their response to ␤-adrenergic stimulation. Figure 4A illustrates the general protocol. Explanted hearts were retrogradely perfused in a Langendorff apparatus, in which a pressure transducer in the tubing carrying perfusate recorded the relative strength of the heartbeat as hearts were perfused with an external solution containing or lacking 1 mol/L isoproterenol (Iso) and 2 mmol/L Ca 2ϩ . In the presence of Ca 2ϩ ( Figure 4A , left), Iso readily exerted a strong inotropic effect, as noted by the increase in the output pressure of heart contractions; in the absence of Ca 2ϩ (right), all contractions were abated, as expected, but perfusion continued nonetheless. After 20 minutes, total perfusion time (marked by asterisk), hearts were flash frozen in liquid nitrogen, pulverized, and homogenized in the presence of phosphatase inhibitors in preparation for Western blots. Figure 4B shows that Iso perfusion activated the ␤-adrenergic pathway and increased PKA activity as the phosphorylation of PLB-Ser16, a specific PKA-phosphorylated residue, yielded a strong signal in the absence and presence of 2 mmol/L Ca 2ϩ . By contrast, phosphorylation of PLB-Thr17 occurred only in the presence of Ca 2ϩ and Iso, supporting the notion that the Ca 2ϩ -and calmodulin-dependent Ca 2ϩ /calmodulin-dependent protein kinase (CaMK)II, which specifically phosphorylates this residue, is secondarily activated by ␤-adrenergic stimulation. 19 RyR2-S2808 was again found phosphorylated in WT hearts, as Iso perfusion increased band intensity Ͻ2-fold, both in the presence and absence of Ca 2ϩ . By contrast, in the same WT hearts, Iso increased the level of RyR2-S2030 phosphorylation Ϸ7and Ϸ3-fold in the presence and absence of Ca 2ϩ , respectively, clearly indicating that this phosphoepitope is markedly sensitive to ␤-adrenergic stimulation and a Ca 2ϩ -stimulated kinase (or a Ca 2ϩ -inhibited phosphatase). The CaMKIIspecific RyR2-S2815 was weakly phosphorylated under basal conditions and, oddly, Iso and Ca 2ϩ did not increase phosphorylation substantially, as would be expected from the vigorous activation of CaMKII noted by PLB-pT17. Figure 4C displays the average response to ␤-adrenergic stimulation of each RyR2 phosphoepitope in WT and RyR2-S2808A hearts, normalized to its own control in the absence of Iso and corrected by the anti-RyR2 signal obtained from the same blot. In general, ␤-adrenergic stimulation increased phosphorylation of all 3 sites in WT PvuII and hybridized to 5Ј and 3Ј probes. The 7.6-kb band represents the WT chromosome and the 5.6 and 3.9-kb bands represent the targeted chromosome hybridized with the 5Ј or 3Ј probe, respectively. C, PCR confirmation of WT, knock in, and heterozygous mice. The 500-bp and 335-bp bands indicate the presence of the homozygous and WT alleles, respectively. D, Immunocytochemistry of cardiomyocytes from WT and RyR2-S2808A mice labeled with antibodies against RyR x /Alexa488 goat anti-mouse or RyR2-pS2808/Rhodami-neRed goat anti-rabbit. E, Coomassie gel and Western blot of WT and RyR2-S2808A mouse microsomes using the RyR2-pS2808 antibody.
hearts, but the participation of S2030 was the greatest. In RyR2-S2808A hearts, Iso increased the S2030 and S2815 phospho-signals more intensely than in WT hearts, perhaps as a compensatory mechanism for the lack of S2808 phosphorylation.
Normal Ca 2؉ Transients and ␤-Adrenergic Response in RyR2-S2808A-Isolated Cardiomyocytes
␤-Adrenergic stimulation of cardiac cells results in RyR phosphorylation ( Figure 4 ) and increased Ca 2ϩ -induced Ca 2ϩ release, 1-3 but the modulatory role of PKA phosphorylation on RyRs remains debated. We measured the amplitude and kinetics of field-stimulated [Ca 2ϩ ] i transients and cell shortenings in isolated ventricular myocytes from WT and RyR2-S2808A mice, both under control conditions (basal) and after ␤-adrenergic stimulation (ϩ1 mol/L Iso) of the same cells. Figure 5 shows that, except for the slower time constant of decay () of the [Ca 2ϩ ] i transient at 1 and 2 Hz in RyR2-S2808A cells, all parameters were similar for the 2 populations of cells. In the presence of Iso, the amplitude and kinetics of the [Ca 2ϩ ] i transient as well as the magnitude of cell contraction increased, as expected, but there were no differences between the 2 groups. We also determined the size of the caffeine-releasable Ca 2ϩ pool at various pacing frequencies to estimate the amount of SR Ca 2ϩ load, but, again, there were no differences between WT and RyR2-S2808A cells (see supplemental Figure I 
Ca 2؉ Sparks and Wavelets in Permeabilized WT and RyR2-S2808A Cells
Ca 2ϩ sparks represent the coordinated opening of a cluster of RyR2s gating in situ 20 and may be used as direct indicators of the effect of modulators on RyR2 activity. Previous experiments have shown that perfusion of cAMP onto permeabilized mouse ventricular cells activates membrane-bound PKA, which in turn phosphorylates SR proteins and increases Ca 2ϩ spark activity. 6 Figure 6A shows Ca 2ϩ spark images obtained from permeabilized WT and RyR2-S2808A cardiomyocytes before and after the addition of 10 mol/L cAMP while in the presence of the CaMKII inhibitor KN-93 (1 mol/L). To prevent dephosphorylation by endogenous phosphatases, okadaic acid (5 mol/L) was added to the perfusate. cAMP promptly increased Ca 2 ϩ release, turning discrete Ca 2ϩ release events into coalescing and laterally propagating wavelets that hampered quantification of isolated Ca 2ϩ sparks. We thus obtained the integral of the amplitude (⌬F/F 0 ) multiplied by the full width (in micrometers) and full duration (in milliseconds) of all Ca 2ϩ release events (sparks and wavelets) and plotted results against the same parameter obtained before cAMP addition; each cell, then, was used as its own control. Figure 6B shows that cAMP vigorously increased Ca 2ϩ release in WT and RyR2-S2808A cells Ͼ200% at all time points, yielding a significant difference against Ca 2ϩ release events in the absence of cAMP (*PϽ0.05; **PϽ0.001), but no difference was seen between WT and RyR2-S2808A cells at any time point. Thus, these results suggest that the RyR2-S2808 phosphoepitope is not a critical determinant of Ca 2ϩ spark activity, at least at the quasidiastolic (50 nmol/L) [Ca 2ϩ ] used here.
Direct Recording of WT and RyR2-S2808A Channel Activity in Lipid Bilayers
Ca 2ϩ sparks and spontaneous Ca 2ϩ release are meaningful assays of RyR2 activity, but their interpretation is complicated by uncontrolled luminal and cytosolic factors that also influence channel activity. We reconstituted SR vesicles into planar lipid bilayers and recorded single-channel activity under controlled conditions to directly assess the effect of phosphorylation on isolated RyR2s. 12, 17 SR vesicles were first treated for 10 minutes with 10 U/mL protein phosphatase (PP)1 to remove any residual phosphorylation present in RyR2 channels. Using Western blots, we provide evidence that the RyR2 channels were dephosphorylated by PP1 at S2808 and S2030 under these starting conditions ( Figure 7A) . Dephosphorylated WT and RyR2-S2808A channels exhibited robust channel activity at cis (corresponding to cytosolic side) [Ca 2ϩ ]ϭ5 mol/L ("Control, pCa 5.3"), as shown in the representative traces of Figure 7B . On average, the probability of the channel being open (P o ) was similar for WT and RyR2-S2808A channels (0.41Ϯ0. 12 [nϭ15] and 0.39Ϯ0.08 
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[nϭ13], respectively), as expected if the phosphorylation state were identical in both types of channels. The addition of 2 mmol/L MgATP (0.35 mmol/L free Mg 2ϩ ) decreased channel activity (0.12Ϯ0.06 and 0.14Ϯ0.04 for WT and RyR2-S2808A, respectively), also as expected from the competitive effect of Mg 2ϩ on the Ca 2ϩ -activation site. 21 Decreasing cytosolic [Ca 2ϩ ] to 100 nmol/L (pCa 7) deactivated channels almost completely (P o Ͻ0.0001 in both groups), with only brief openings being detected sporadically. Addition of 1 g/mL the catalytic subunit of PKA failed to increase P o in WT and RyR2-S2808A channels (P o Ͻ0.0001); however, after the return of cytosolic [Ca 2ϩ ] to prephosphorylation levels (pCa 5.3), WT channels displayed consistently lower P o (0.08Ϯ0.03) than RyR2-S2808A channels (0.22Ϯ0.05) (last traces of Figure 7B ). The latter was the only difference between WT and RyR2-S2808A channels more than the course of the experiment, represented in Figure 7C and 7D. Again, using Western blots, we show that PKA effectively phosphorylates both S2808 and S2030 sites under the conditions used in the bilayer experiments ( Figure 7A , "pCa7, MgATP, PKA"). We therefore assign the difference in WT and RyR2-S2808 channel activity at pCa 5.3 to the phosphorylation of S2808 in WT channels. The inhibition at high [Ca 2ϩ ] caused by PKA phosphorylation of WT channels is consistent with our previous report which suggested that PKA increased the transient peak of RyR2 activity but decreased its steady-state activity (see Discussion). 12
Discussion
In this study, we demonstrate that stimulation of ␤-adrenergic receptors by Iso in whole hearts leads to phosphorylation of several RyR2 phosphoepitopes (Figure 4 ). RyR2 channels, therefore, appear to be integral components of the multiprotein response that leads to increased cardiac performance during ␤-adrenergic stimulation, but the extent of their participation in the "fight-or-flight" response remains debated. Ca 2ϩ release by RyR2 is steeply graded by I Ca and luminal Ca 2ϩ , both of which increase during ␤-adrenergic stimulation because of PKA phosphorylation of L-type Ca 2ϩ channels and PLB, respectively 1 ; hence, it appears that RyR2 channels need only be responsive to external cues to increase Ca 2ϩ release, but this passive compliance negates the necessity for direct RyR2 protein phosphorylation. Some outstanding questions, therefore, are the following. What are the intrinsic changes in RyR2 function brought about by PKA phosphorylation? Is this functional modulation conspicuous enough to modify global Ca 2ϩ transients, cardiac performance, and be a substrate for development of cardiac arrhyth- mias and HF? In an attempt to answer these questions, we generated a mouse with ablation of a major PKA phosphorylation site (RyR2-S2808A) and found that RyR2 phosphorylation results in discernible effects on single-channel activity that are obscured by a multitude of cellular adjustments in response to sympathetic stimulation. Aortic-banded RyR2-S2808A and WT mice developed cardiac hypertrophy and systolic dysfunction equally, suggesting that PKA phosphorylation of Ser2808 does not significantly impact the maladaptive cardiac remodeling following chronic stress. Because RyR2-S2808A mice compensated for the lack of Ser2808 phosphorylation by augmenting the participation of other phosphoepitopes (Figure 4 ), our results do not rule out that RyR2 phosphorylation is a central mechanism in the cellular response to acute or chronic stress, but they are at odds with other reports that place this mutation alone as a key determinant of SR Ca 2ϩ leak, 8, 9 cardiac protection in HF progression, 10 or exercise-induced cardiac arrhythmias. 7
Control Mechanisms of Diastolic Ca 2؉ Leak: RyR2 Phosphorylation Versus SR Load
Diastolic Ca 2ϩ leak normally offsets Ca 2ϩ release and uptake imbalances to stabilize SR Ca 2ϩ load during contractions; however, an increase in the rate of diastolic Ca 2ϩ leak may induce Ca 2ϩ -dependent arrhythmias and is probably a key determinant of the contractile dysfunction that characterizes HF. 22, 23 In principle, an increase in diastolic Ca 2ϩ release may be caused by any mechanism that increases SR Ca 2ϩ load or by those that increase RyR2 activity or both. Whereas it is progressively clear that diastolic Ca 2ϩ leak (and systolic Ca 2ϩ release) is greatly dependent on SR load, 22, 24 the role of RyR2 modulation remains less obvious. 23 Recently, Eisner's group has shown that modulators of RyR2 (caffeine, tetracaine)
quickly modify the magnitude of the [Ca 2ϩ ] i transient but also that the change in SR load brought about by the modified RyR2 prevents long-term effects. In this scenario, modulation of RyR2 activity may influence diastolic Ca 2ϩ leak but the effect would be contingent on SR Ca 2ϩ load. 24 In single-channel experiments, we previously showed that PKA phosphorylation of canine RyR2 results in complex kinetic responses, mainly increasing its transient peak P o in response to a rapid rise in activating [Ca 2ϩ ], but also modestly decreasing its activity at steady [Ca 2ϩ ] (pCa 5). 12 PKA phosphorylation, therefore, produces a RyR2 with faster activation and relaxation kinetics to the trigger Ca 2ϩ , which in cellular settings would translate into increased rates of Ca 2ϩ release and faster turn off of release for a given I Ca , both of which are detected experimentally. 25 At no point did we observe an increase in RyR2 activity at diastolic [Ca 2ϩ ]. Presently, we show that mouse RyR2, like canine 12 and human 17 RyR2, fails to modify its activity in response to PKA phosphorylation (Figure 7 ) at diastolic [Ca 2ϩ ] (pCa 7). Ablation of the S2808 phosphoepitope, presumably the center of PKA effects, 7-10 did not confer gain-of-function. Nevertheless, after return to activating cytosolic [Ca 2ϩ ] (pCa 5), PKA-phosphorylated RyR2-S2808A channels consistently displayed increased activity compared with their WT counterparts. Western blots conducted under conditions closely resembling those in the bilayer experiments clearly show dephosphorylation of S2808 by PP1 and phosphorylation of S2808 and S2030 by PKA, supporting the notion that the purported effects (or lack thereof) of phosphorylation seen in bilayers were indeed manifestations of the phosphorylation state of RyR2.
Overall, the above results and those obtained in cells suggest important conclusions. (1) PKA phosphorylation of RyR2 alone (either at S2808 or S2030 or both) does not appear to constitute a major mechanism to increase diastolic Ca 2ϩ leak; additional factors appear to be needed, likely, increased SR Ca 2ϩ load. 6, 22, 24 In support of this, cAMP increased Ca 2ϩ spark activity in permeabilized cells of WT and RyR2-S2808A hearts ( Figure 6 ), most likely by phosphorylation of PLB and the subsequent increase in SR load, as shown by Li et al. 6 (2) PKA phosphorylation of S2808 does modify RyR2 activity, ie, it attenuates RyR2 activity when [Ca 2ϩ ] is high (shown by differences in P o of WT and RyR2-S2808A channels at pCa 5.3; Figure 7C and 7D, dotted line), probably contributing to the relative Ca 2ϩ insensitivity of RyR2 in vivo 26 and the faster turn off of release seen in bilayers 12 and cellular 25 settings, but the effect appears modest and is likely obscured by other modulators of RyR2s that are relevant when Ca 2ϩ is high, namely, Ca 2ϩ itself (I Ca ), and the SR Ca 2ϩ load that increases during diastole. This is supported by the lack of prominent effects of S2808 ablation on Ca 2ϩ transients and the full restoration of cellular function on ␤-adrenergic stimulation ( Figure 5 ). The role of other RyR2 phosphorylation sites that are Ca 2ϩ activated (such as the CaMKII-phosphorylated S2815 site) remains to be defined, but this site played no role in our cellular experiments because we omitted calmodulin and added KN-93, a specific CaMKII blocker. (3) PKA readily phosphorylated S2030 in vitro (Figures 3 and 7) and likely in vivo as well (Figure 4 ), but phosphorylation of this site, like S2808, was insufficient to activate RyR2 at diastolic [Ca 2ϩ ]. Although conclusions on the role of S2030 in cellular Ca 2ϩ handling cannot be firmly drawn because RyR2-S2808A hearts tended to overphosphorylate this site (Figure 4 ), in vitro experiments were done at quasiequivalent levels of S2030 phosphorylation (Figure 7 ) and yielded modest effects as well.
Comparison With Other Results
The effects of PKA phosphorylation of RyR2 have been investigated in several animal species, including human, and at different levels of integration, from single-channel effects to whole-heart physiology. The results do not always converge, and a unifying theme has not been found, for reasons that are only now starting to emerge. First, whereas all 3 clearly identified phosphorylation sites are present in the RyR2 protein of all mammals investigated, there appears to be variability in their basal level of phosphorylation, which could account for different outcomes. For example, Carter et al 18 found high basal levels of phosphorylation of S2809 (Ϸ70% of all sites) in sheep heart homogenates, like we did here in mice, and associated steep changes in RyR2 activity with small changes in the phosphorylation of this site. However, not all species appear as eager to phosphorylate S2808 basally, ie, canine and rat RyR2 can be substantially phosphorylated at this site by PKA. 17 Second, while investigating the effects of PKA, very few studies have carefully controlled SR load, which, as discussed above, profoundly influences RyR2 activity and may conceivably override phosphorylation effects. [22] [23] [24] Furthermore, SR load may dramatically influence the propensity of RyR2 to undergo phosphorylation, as the latter process appears to be modulated by the open state of the channel. 27 All of this may account, in whole or in part, for the activation, 7-11 inhibition 12, 13 or lack of effect 14 of PKA phosphorylation on RyR2.
The issues above that cloud the interpretation of PKA effects may be overcome in studies in which precise control of RyR2 phosphorylation is achieved, SR load is controlled, and animal models with selective ablation of the incumbent phosphorylation site may be tested side-by-side with WT controls. However, even then, outstanding differences may remain, as demonstrated with this study and the results of Wehrens et al. 10 Using mice with an identical genetic mutation (RyR-S2808A), they place S2808 phosphorylation in a privileged position to control RyR2 activity in health and disease. First, they found that RyR2-S2808A does not dwell in subconducting states after PKA phosphorylation, as WT channels do. Others 11, 13, 14, 18 and we 12, 17 have not found subconducting states in RyR2 as the hallmark of PKA phosphorylation. Second, in their hands, RyR2-S2808A channels cannot be PKA phosphorylated. 10 Our in vitro phosphorylation protocol (Figure 4 ) clearly shows incorporation of [␥-32 P]-ATP in RyR2-S2808A channels, and phosphospecific antibodies reveal that S2030 is also phosphorylated by PKA, as previously shown. 16 This difference is thus perplexing, but a potential explanation is that the S2030 site appears sensitive to endogenous phosphatases, as we found that SR-embedded RyR2-S2808A proteins were substantially less phosphorylated than their immunoprecipitated counterparts (not shown). Wehrens et al 10 could have immunoprecipitated more phosphatases than we did in our assays. Lastly, their RyR2-S2808A mice were substantially protected after myocardial infarction, whereas we found no protection following aortic banding. Again, a potential source of disparate results is that myocardial infarction, which involves substitution of dead cells with scar tissue, may bring about radically different cellular adaptation than aortic banding, which exerts even stress on the left ventricle and is unlikely to ramp up apoptosis. Both models, however, produce chronic activation of the ␤-adrenergic pathway and should equally elicit longterm activation of PKA.
In summary, we found that PKA phosphorylation of RyR2 leads to modest effects discernible in single-channel assays.
Phosphorylation of the S2808 residue appears to attenuate RyR2 activity at high Ca 2ϩ only, leaving diastolic Ca 2ϩ responses unaffected and hence unlikely to mediate a proposed PKA-driven increase in SR Ca 2ϩ leak. This effect is obscured by the complex interactive array of proteins phosphorylated by PKA during sympathetic stimulation, as [Ca 2ϩ ] i transients in WT and RyR2-S2808A cardiomyocytes appear similar during ␤-adrenergic stimulation. Ablation of this site offers little protection during chronic stress, implying a limited role for RyR2-S2808 phosphorylation in the pathogenesis of HF.
